Shingles vaccination can cut older adults’ risk of developing dementia, study says
- A new study found shingles vaccination cut older adults' risk of developing dementia over the next seven years by 20%.
- The study tracked people in Wales who were around 80 when receiving the world's first-generation shingles vaccine over a decade ago.
- Now, Americans 50 and older are urged to get a newer vaccine that's proven more effective against shingles than its predecessor.
148 Articles
148 Articles


Shingles vaccine appears to protect against dementia
Older people who were vaccinated against shingles had a significantly lower risk of developing dementia than those who were not vaccinated, according to a recent study that followed a large number of older people.
New Study Shows Shingles Vaccine Linked To 20% Lower Dementia Risk, GSK Stock Pops - GSK (NYSE:GSK)
Researchers investigated whether the shingles (herpes zoster) vaccine can help prevent dementia. Previous studies suggest that certain herpes viruses may contribute to dementia, and vaccines might have immune benefits. The new research, published on Wednesday, Nature analyzed data from 282,541 older adults in Wales and found that people who received the original shingles live virus vaccine were 20% less likely to develop dementia than non-vaccin…
Coverage Details
Bias Distribution
- 58% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage